Thomas Joseph Dee
Corporate Officer/Principal bei Abbott Laboratories Trading (Shanghai) Co. Ltd.
Aktive Positionen von Thomas Joseph Dee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
 Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | 22.09.2011 | - |
Karriereverlauf von Thomas Joseph Dee
Ehemalige bekannte Positionen von Thomas Joseph Dee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVEXIS INC | Finanzdirektor/CFO | 01.08.2015 | 19.10.2017 |
| ABBOTT INDIA LIMITED | Direktor/Vorstandsmitglied | 09.04.2008 | 30.09.2013 |
| Independent Dir/Board Member | 22.09.2011 | 26.04.2013 | |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01.01.1990 | 01.04.2011 |
| Corporate Officer/Principal | 01.04.2011 | 01.09.2013 |
Ausbildung von Thomas Joseph Dee
| Northern Illinois University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| Indien | 2 |
| China | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBOTT INDIA LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Börse
- Insiders
- Thomas Joseph Dee
- Erfahrung
